<i>EPG5</i> -related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy

Susan Byrne(St Thomas' Hospital), Max Janse(King's College London), Jean-Marie U-King-Im(St Thomas' Hospital), Ata Siddiqui(St Thomas' Hospital), Hart G.W. Lidov(Boston Children's Hospital), István Bódi(King's College Hospital), Luke J. Smith(King's College London), R. Mein(Guy's Hospital), Thomas Cullup(Great Ormond Street Hospital), Carlo Dionisi‐Vici(Bambino Gesù Children's Hospital), Lihadh Al‐Gazali(United Arab Emirates University), Mohammed Al‐Owain(Alfaisal University), Zandrè Bruwer(Sultan Qaboos University Hospital), Khalid Al Thihli(Sultan Qaboos University Hospital), Rana El-Garhy(Ain Shams University Hospital), Kevin M. Flanigan(Nationwide Children's Hospital), Kandamurugu Manickam(Nationwide Children's Hospital), Erik Zmuda(Nationwide Children's Hospital), Wesley Banks(Nationwide Children's Hospital), Ruth Gershoni‐Baruch(Rambam Health Care Campus), Hanna Mandel(Rambam Health Care Campus), Efrat Dagan(University of Haifa), Annick Raas‐Rothschild(Tel Aviv University), Hila Barash(Tel Aviv University), Francis Filloux(Primary Children's Hospital), Donnell J. Creel(University of Utah), Michael A. Harris(Georgetown University), Ada Hamosh(Johns Hopkins University), Stefan Kölker(Heidelberg University), Darius Ebrahimi‐Fakhari(Heidelberg University), Georg F. Hoffmann(Heidelberg University), David Manchester(Children's Hospital Colorado), Philip J. Boyer(East Carolina University), Adnan Y. Manzur(Digital Catapult (United Kingdom)), Charles Marques Lourenço(Universidade de São Paulo), Daniela T. Pilz(University Hospital of Wales), Arveen Kamath(University Hospital of Wales), Prab Prabhakar(Great Ormond Street Hospital), Vamshi K. Rao(Children's Hospital & Medical Center), R. Curtis Rogers(Greenwood Genetic Center), Monique M. Ryan(Royal Children's Hospital), Natasha J. Brown(The University of Melbourne), Catriona McLean(Alfred Health), Edith Said(University of Malta), Ulrike Schara(University of Duisburg-Essen), Anja Stein(University of Duisburg-Essen), Caroline A. Sewry(Great Ormond Street Hospital), Laura Travan(IRCCS Materno Infantile Burlo Garofolo), Frits A. Wijburg(University of Amsterdam), Martin Zenker(University Hospital Magdeburg), Shehla Mohammed(Guy's Hospital), Manolis Fanto(King's College London), Mathias Gautel(King's College London), Heinz Jungbluth(St Thomas' Hospital)
Brain
February 25, 2016
Cited by 141Open Access
Full Text

Abstract

Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identified 39 different EPG5 mutations, most of them truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations (p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with marked hypotonia and feeding difficulties. In addition to the five principal features (callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immune dysfunction), we identified three equally consistent features (profound developmental delay, progressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a specificity of 97%, and a sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24 months (95% confidence interval 0-49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes were significantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative component superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradiological features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and, less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included fibre size variability, central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities. Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients confirmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5 (CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related Vici syndrome defines a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deficient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.


Related Papers

No related papers found

Powered by citation graph analysis